Oxaprozin potassium

奥沙普秦钾

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOxaprozin potassium
Drug Alias NameOxaprozinum potassiumDaypro Alta
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsOsteoarthritisArthritis, Rheumatoid
Global Approved IndicationsOsteoarthritisArthritis, Rheumatoid
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2002/10/17
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsOsteoarthritisArthritis, Rheumatoid

Other Information

ATC CodeM01AE12
Related LinksWikipediaDrugBank